Fundraising Fox
/Companies
Sign in

EmVenio Research

Sparks, US · Founded 2022 · 1 known investors

Find your way into EmVenio Research

Sign up to see every warm intro you have to EmVenio Research

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the EmVenio Research team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

EmVenio runs decentralized clinical research through in-home patient visits, community-based research sites, and patient navigation services, helping trial sponsors and CROs reach underrepresented populations. It supports clinical trial recruitment, retention, and data capture across more than 90 countries.

BiotechDigital HealthEnterprise SoftwareHealthtech

Founders & leadership

GAGreg Austin
Greg AustinGreg Austin has served as President of Professional Case Management and EmVenio since 2005, leading a large team in decentralized clinical research and patient care services.
MMMark McKenzie
Mark McKenzieM.D.M.D. at EmVenio
JHJeff Huntsman
Jeff HuntsmanJeff Huntsman leads EmVenio, a decentralized clinical research platform serving trial sponsors and CROs. He previously held commercial and executive leadership roles focused on sales strategy, business development, and organizational growth in pharmaceutical, healthcare technology, and SaaS sectors.
TB
Tajuana BarronFounder at EmVenio
TO
Tom O'ConnorTom O'Connor has held leadership roles spanning home healthcare, clinical research, and telecommunications, with expertise in decentralized clinical trials and international market expansion across both startups and established companies.
CC
Christy Crase
TW
Thaddeus WolframNamed on SEC filing
MW
Monty WaughNamed on SEC filing
AH
Alan HenthorneNamed on SEC filing
DC
Daniel CastilloNamed on SEC filing
DSDavid Shackelton
David ShackeltonNamed on SEC filingInvestor at Reno Seed Fund
CB
Charlie Billings

Investors · 1

Reported raises · per SEC filings

Form D private placements

$9.2M disclosed across 1 round · 2022

▶$9.2MraisedDec 2022 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thaddeus WolframExecutive Officer
  • Monty WaughExecutive Officer
  • Alan HenthorneExecutive Officer, Director
  • Daniel CastilloExecutive Officer
  • David ShackeltonExecutive Officer, Director
Offering amount
$10M
Amount sold
$9.2M
Minimum investment
$50K
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does EmVenio Research do?
EmVenio runs decentralized clinical research through in-home patient visits, community-based research sites, and patient navigation services, helping trial sponsors and CROs reach underrepresented populations. It supports clinical trial recruitment, retention, and data capture across more than 90 countries.
Who are EmVenio Research's investors?
EmVenio Research's investors include Reno Seed Fund.
How much funding has EmVenio Research raised?
EmVenio Research has disclosed $9.2M raised across 1 round.
Where is EmVenio Research headquartered?
EmVenio Research is headquartered in Sparks, US.